Related Experiment Video
Updated: Sep 2, 2026

Direct Detection of the Acetate-forming Activity of the Enzyme Acetate Kinase
Published on: December 19, 2011
Uncertainty Quantification with Domain Classification Models for Acetylcholinesterase Inhibition
Joshua S Harris1, Patricia A Vignaux1, Thomas R Lane1
1Collaborations Pharmaceuticals, Inc., 1730 Varsity Drive, Suite 360, Raleigh, North Carolina27606-5228, United States.
Abstract:
Uncertainty quantification is crucially important for small-molecule machine learning (ML) models. For companies and regulatory bodies that rely on ML models to inform high-cost and high-risk decisions, accurate uncertainty quantification can reveal whether a given prediction is trustworthy. Existing methods for uncertainty quantification have been shown to be less reliable outside of a model's applicability domain. We have developed a novel approach to uncertainty quantification called domain classification (DC) modeling, which combines results from three independent binary classification models to capture the relationship between the subsets of active and inactive molecules in a training set, as well as a large and diverse "out of domain" set. Applying this modeling approach to acetylcholinesterase inhibition, we show that it robustly captures aleatoric and epistemic uncertainty even for molecules far outside the applicability domain. We show that filtering predictions with uncertainty-based thresholds leads to superior prediction performance even for external test sets with significant out-of-domain character, at the cost of discarding uncertain predictions. In particular, while screening out the top 50% of uncertain predictions from a binary random forest model, recall on external test sets improves from 0.56 to 0.80, precision improves from 0.82 to 0.87, and specificity stays about the same (0.92 to 0.91). While screening out 70% of predictions, recall and precision increase to 0.91 and 0.92, respectively, while specificity stays at 0.92. Improvements in recall and precision are statistically significant with a p-value of 0.05, whereas there is no significant change in specificity. We also use DC modeling to define uncertainty windows for prediction probabilities based on confidence levels and demonstrate that these confidence levels accurately represent the likelihood that ground truth activity probabilities fall within the uncertainty window.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinesterases: Distribution and Function
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...